When would you continue atezolizumab/bevacizumab beyond progression in advanced HCC?
What parameters do you use to decide to treat beyond progression? Is there any efficacy data from this specific study subgroup in IMbrave150?
Community PollStarted
When would you continue atezolizumab/bevacizumab beyond progression in advanced HCC?
37 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet Member
Medical Oncology · University of Colorado School of Medicine
Answered on
The key parameters I use when considering treatment beyond progression for a patient on atezolizumab bevacizumab are clinical symptoms as compared to baseline, performance status as compared to baseline, and underlying hepatic function as compared to baseline. If there is worsening in any of these a...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Medical Oncology · Geffen School of Medicine at UCLA
Answered on
There are many effective drugs now in HCC. If there is true progression, I would change therapy. What is true progression? I think, a confirmed new lesion and/ or significant growth of the current disease. A few mm seen on a scan sometimes is read by radiology as PD but if the lesion is 8 mm, it's n...
Join for free or sign in to see the full answer